Melt&Marble, the Swedish BioTech scale-up using precision fermentation to produce designer fats, has just raised €7.3 million in Series A funding, to scale production and bring its first ingredients to market. Designed to deliver enhanced functionality, taste and even health outcomes, the company’s ingredients offer sustainable, high-performance alternatives to conventional oils and fats for use in personal care and food applications.
The €7 million Series A round was led by Swedish DeepTech investor Industrifonden, with participation from the European Commission’s European Innovation Council (EIC) Fund and strategic partners Beiersdorf and Valio, key players in the personal care and food sectors, respectively. Additional backing came from Chalmers Ventures and Catalyze Capital. The EIC Accelerator also supported with an additional €2.5 million grant last year, bringing latest funding to a total of €10 million over the past year.
Melt&Marble was founded in 2014 in Gothenburg, and the fresh funding marks a pivotal moment for Melt&Marble, signalling cross-sector validation of its technology platform and commercial strategy. With investors spanning venture capital, industry, and European innovation policy, the round brings together deep expertise and networks critical for scaling precision fermentation solutions.
“This investment marks a major milestone for Melt&Marble as we transition from R&D to commercialisation. With key scalability milestones already achieved and strategic partners onboard, we’re entering the market with the capabilities and confidence to deliver real impact. Our vision has always been to deliver more sustainable, high-performance ingredients, and this round brings us significantly closer to that goal,” said Anastasia Krivoruchko, CEO of Melt&Marble.
Tobias Elmquist, Senior Investment Director at Industrifonden, commented: “Melt&Marble has achieved an impressive level of technical and commercial readiness for a company at this stage. Their ability to engineer functional fats through precision fermentation addresses a clear and growing demand across industries. We’re proud to lead this round and support a team combining scientific depth with strong execution to bring sustainable, high-performance ingredients to market.”
The market opportunity for oils, fats and lipids relevant for Melt&Marble’s platform is estimated to be worth more than $100 billion, covering personal care and beauty, meat and dairy alternatives, chocolate confectionery, bakery and specialised nutrition. As brands in food and personal care race to meet sustainability targets and consumer demand for high performance ingredients, fats are a critical piece of the puzzle. Traditional fats like palm, coconut, and animal-based sources often struggle with performance, supply volatility, and environmental criteria. Melt&Marble’s precision fermentation platform offers animal-free, tailored fat structures that unlock superior functionality, from texture and mouthfeel in food to enhanced skin-feel and bio-activity in cosmetics.
Melt&Marble is creating ingredients that deliver on functionality, impact and cost. By engineering fats from the molecule up, the Swedish scale-up can deliver cost-competitive, locally produced ingredients that meet both technical demands and sustainability goals. Strategic backing from Beiersdorf and Valio is a reflection of the good product-market fit across these high-performance sectors.
Ascan Voswinckel, Head of Venture Capital at Beiersdorf stated: “Melt&Marble is addressing an important challenge in the personal care industry, with its advanced innovative precision-fermentation technology. With consumer interest in more sustainable and responsible skincare products growing, Beiersdorf is pleased to invest in Melt&Marble, and support their highly committed, science-driven team as they aim to advance sustainability across multiple industries.”
Melt&Marble’s product pipeline spans fats designed to unlock functionality across multiple categories, including alternative meat and dairy, bakery, chocolate, skincare, and haircare. The new funding will take Melt&Marble from demo to market-ready, with its first ingredients set for commercial launch in personal care applications in 2026. Production volumes will be delivered through an existing commercial manufacturing partner, ensuring capex-light scalability. Alongside a focus on Europe, the company is also preparing for food market entry in the US, where regulatory pathways allow for faster deployment, and eyeing other geographies for further expansion. Commercial collaboration and distribution discussions are underway and Melt&Marble is actively working on co-development products with partners in preparation for a commercial launch.
Svetoslava Georgieva, Chair of the EIC Fund Board, added: “Melt&Marble’s precision-fermentation approach to designer fats offers sustainable, high-performance alternatives for food and personal care. This Series A round is a strong endorsement of their technology. The EIC Fund is proud to support their scale-up and market entry.”
The funding news comes as Melt&Marble continues to explore opportunities with industry players across multiple regions, buoyed by strong application results and major advances in bioprocess efficiency. These achievements potentially mark the company’s next phase of growth, as it moves toward commercialising precision-designed fats and lipids and contributing to a more sustainable future for food and personal care.
Read the orginal article: https://www.eu-startups.com/2025/12/swedish-biotech-company-meltmarble-secures-e7-millon-to-scale-designer-fats-in-beauty-and-food/
